ArticleMolecular cancer2020

Downregulation of MYPT1 increases tumor resistance in ovarian cancer by targeting the Hippo pathway and increasing the stemness.

Sandra Muñoz-Galván et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.